Cardinal Health beats revenue and profit estimates, raises FY27 earnings outlook
Cardinal Health topped analyst expectations for fiscal first-quarter revenue and adjusted earnings per share, and raised its fiscal 2027 profit guidance.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
US pharmaceutical distributor Cardinal Health reported that fiscal first-quarter revenue rose 5%, ahead of analyst forecasts. Adjusted earnings per share climbed 28%, also above expectations. Reuters attributes the figures to the company and LSEG data.
The company lifted its fiscal 2027 non-GAAP EPS guidance to $12.80–$13.00 from $12.40–$12.60. It now expects profit growth in its Pharmaceutical and Specialty Solutions segment of 10% to 12%, up from 8% to 11%. The non-GAAP effective tax rate outlook was narrowed to 18.5%–19.5% from 19.0%–20.0%.
Segment profit in Pharmaceutical and Specialty Solutions rose 17% during the quarter, mainly on brand and specialty products and a positive generics program. Net income reached $554 million.
why it matters
For the market, this signals resilience in the drug distribution business. Higher revenue and profit, a lower tax rate and a smaller share count all support earnings expectations. According to Reuters, the average analyst rating on the shares is buy, and the median 12-month price target is $280.
market impact
Cardinal Health shares: earnings beat and raised guidance support the stock
- Cardinal Health shares pressure up — earnings beat and raised guidance support expectations for profit
tags
instruments
sources
- Cardinal Health beats Q1 revenue, adjusted EPS estimates, raises outlook — Reuters, 5 November 2026 at 11:53 UTC
- Tapestry Q1 revenue and adjusted EPS beat estimates, outlook raised — Reuters, 5 November 2026 at 11:53 UTC
- Astrana Health Q3 adjusted EPS beats, revenue meets estimates — Reuters, 5 November 2026 at 21:45 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗